HCPCS Level II code G0068 designates professional services for administration of non-chemotherapy intravenous infusion drugs or biologicals in the patient’s home, billed per 15-minute increment for each calendar day of infusion. The code applies to a range of therapies including anti-infectives, pain management infusions, chelation, pulmonary hypertension agents, and inotropic support, excluding chemotherapy and other highly complex biologic agents. Nationally, this code matters because home infusion is an expanding site of care that affects clinical workflows, home health capacity, and payment models for outpatient drug administration.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an outline of clinical and billing context for use of G0068, common billing considerations, and where to look for policy guidance. The publication summarizes typical service scenarios, expected site-of-service implications, and benchmarking and policy topics relevant to home infusion professional services. It also identifies gaps where specific payer policy details, modifier guidance, or taxonomy mapping are not provided in the input. Data not available in the input will be noted where applicable.